/Investor DB

Leafy Tunnel — 2024 Investments

2 investments dated 2024 · listed companies and verified rows first · show all

Ceretypeceretype.cominJan 2024 · $2M

Ceretype develops brain imaging and analysis tools that provide insights into brain circuitry for therapeutic development and clinical care of psychiatric and neurological disorders.

AI & Machine LearningBiotechDigital HealthMedical Devices

Emily Stern(CEO)inRoni Setton(Scientific Director)in

BoardDavid Silbersweig(SAB Chair)

Co-investorsJLS

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Ceretype Neuromedicine

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.